Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.652 SEK | -4.73% | -11.28% | -6.77% |
Apr. 29 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 | |
Apr. 29 | Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina | CI |
Business Summary
Number of employees: 11
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Non-invasive Blood Tests
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +35.66% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
59.1
%
| 1 | 59.2 % | 1 | 59.1 % | +35.40% |
United States
40.9
%
| 0 | 0.0 % | 0 | 40.9 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 22-03-31 | |
Karl Stone
COO | Chief Operating Officer | 61 | 23-02-28 |
Chief Tech/Sci/R&D Officer | - | 23-01-31 | |
Linda Mellby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas C. King
CTO | Chief Tech/Sci/R&D Officer | 66 | 16-12-31 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 22-01-19 |
Tobias Bülow
IRC | Investor Relations Contact | - | 22-01-14 |
Cindy Callahan
SAM | Sales & Marketing | - | - |
Jon Hager
SAM | Sales & Marketing | - | 22-12-04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 16-12-08 | |
Peter Andersen
CHM | Chairman | 67 | 19-12-31 |
Michael Löfman
BRD | Director/Board Member | - | 23-05-21 |
Martin Møller
BRD | Director/Board Member | 49 | 20-12-31 |
Eric Krafft
BRD | Director/Board Member | 49 | 22-03-31 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 22-01-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,287,498 | 34,016,137 ( 75.11 %) | 0 | 75.11 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-6.77% | 6.9M | |
-16.33% | 18.62B | |
-42.18% | 2.85B | |
+22.02% | 1.94B | |
+0.39% | 1.68B | |
+27.15% | 1.26B | |
-10.70% | 1.03B | |
-18.27% | 938M | |
+0.66% | 783M | |
-25.07% | 628M |
- Stock Market
- Equities
- IMMNOV Stock
- Company Immunovia AB